Rocuronium 1.5mg/kg/hr for muscle hypotonia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Jan 2019: Trial started, NCT03808077
  2. 17 Jan 2019: Trial registered, NCT03808077

The trials

NCT03808077: The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer

State
Under way
Phase
Phase 2
People
139 taking part
Started
14 Jan 2019
Primary completion
11 Oct 2024
Arms
Interventional Group: Deep Neuromuscular Blockade
Results
Posted on the registry
  1. 14 Jan 2019: Trial started
  2. 17 Jan 2019: Trial registered
  3. 19 Jun 2025: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.